In patients with CKD, especially those with diabetic kidney disease (DKD), baseline downregulation of ACE2 and upregulation of ACE, a combination of proinflammatory and profibrotic states in the kidneys, might lead to CKD progression (11, 29). The gene discussed is ACE2; the disease is chronic kidney disease.